Membrane permeability of trace amines: Evidence for a regulated, activity-dependent, nonexocytotic, synaptic release

Synapse

Volumn 67, Issue 10, 2013, Pages 656-667

  Berry, Mark D ^a,b   Shitut, Mithila R ^b   Almousa, Ahmed ^b   Alcorn, Jane ^b   Tomberli, Bruno ^a  

^a BRANDON UNIVERSITY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

2 phenylethylamine; Dopamine; Fluorosomes; p tyramine; Synaptosomes

Indexed keywords

DOPAMINE; PHENETHYLAMINE; PHENETHYLAMINE DERIVATIVE; SEROTONIN; TRYPTAMINE; TYRAMINE;

ANIMAL CELL; ARTICLE; BILAYER MEMBRANE; CONTROLLED STUDY; DOPAMINE RELEASE; EXOCYTOSIS; FLUOROSOME; LIPID BILAYER; MEMBRANE PERMEABILITY; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

EID: 84882865100     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21670     Document Type: Article

References (56)

1. Berry MD. 2004. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90:257-271.
2. Berry MD. 2007. The potential of trace amines and their receptors for treating neurological and psychiatric diseases. Rev Recent Clin Trials 2:3-19.
3. Berry MD. 2011. The effects of pargyline and 2-phenylethylamine on D1-like dopamine receptor binding. J Neural Transm 118:1115-1118.
4. Berry MD, Nickel J, Shitut MR, Tomberli B. 2011. Molecular dynamics-based simulation of trace amine membrane permeability. J Neural Transm 118: 1119-1128.
5. Berry MD, Scarr E, Zhu M-Y, Paterson IA, Juorio AV. 1994. The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine. Br J Pharmacol 113:1159-1166.
6. Blakeley AG, Nicol CJ. 1978. Accumulation of amines by rabbit erythrocytes in vitro. J Physiol 277:77-90.
7. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirani S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C. 2001. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98:8966-8971.
8. Bradaia A, Trube G, Stalder H, Norcross RD, Ozmen L, Wettstein JG, Pinard A, Buchy D, Gassmann M, Hoener MC, Bettler B. 2009. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci USA 106:20081-20086.
9. Breidert T, Spitzenberger F, Grundemann D, Schomig E. 1998. Catecholamine transport by the organic cation transporter type 1 (OCT1). Br J Pharmacol 125:218-224.
10. Bunzow JR, Sonders MR, Arttamangkul S, Harrison LM, Zhang G, Quigley DL, Darlund T, Suchland KL, Pasamamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK. 2001. Amphetamine, 3, 4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181-1188.
11. Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW. 1990. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum. J. Neurochem 55:981-988.
12. Danek Burgess KS, Burgess JB Jr. 1999. Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport. J Neurochem 73:656-664.
13. Durden DA, Philips SR. 1980. Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain. J Neurochem 34:1725-1732.
14. Dyck LE. 1989. Release of some endogenous trace amines from rat strital slices in the presence and absence of a monoamine oxidase inhibitor. Life Sci 44:1149-1156.
15. Dyck LE, Yang CR, Boulton AA. 1983 The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices. J Neurosci Res 10:211-220.
16. Ertl P, Rohde B, Selzer P. 2000. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43:3714-3717.
17. Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS, Caron MG, Gainetdinov RR. 2011. Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol Pharmacol 80:416-425.
18. Fischer W, Neubert RH, Brandsch B. 2010. Transport of phenylethylamine at intestinal epithelial (Caco-2) cells: mechanism and substrate specificity. Eur J Pharm Biopharm 74:281-289.
19. Holland B. 2012. Extension of nonequilibrium work theorems with applications to diffusion and permeation in biological systems. PhD thesis University of Guelph Canada.
20. Inazu M, Takeda H, Matsumiya H. 2005 Molecular and functional characterization of a Na+-independent choline transporter in rat astrocytes. J Neurochem 94:1427-1437.
21. Iseki K, Sugawara M, Saitoh N, Miyazaki K. 1993a. The transport mechanisms of organic cations and their zwitterionic derivatives across rat intestinal brush border membrane. I. Binding characteristics to the bio- and lipid-membranes. Biochim Biophys Acta 1146:121-126.
22. Iseki K, Sugawara M, Saitoh N, Miyazaki K. 1993b. The transport mechanisms of organic cations and their zwitterionic derivatives across rat intestinal brush border membrane. II. Comparison of the membrane potential effect on the uptake by membrane vesicles. Biochim Biophys Acta 1152:9-14.
23. Jones RS 1982a. Noradrenaline-octopamine interactions on cortical neurons in the rat. Eur J Pharmacol 77:159-162.
24. Jones RS. 1982b. Tryptamine modifies cortical neurone responses evoked by stimulation of the nucleus raphe medianus. Brain Res Bull 8:435-437.
25. Jones RS, Boulton AA. 1980. Interactions between p-tyramine, m-tyramine, or β-phenylethylamine and dopamine on single neurons in the cortex and caudate nucleus of the rat. Can J Physiol Pharmacol 58:222-227.
26. Jones RSG, Juorio AV, Boulton AA. 1983. Changes of levels of dopamine and tyramine in the rat caudate nucleus following alterations in impulse flow in the nigrostriatal pathway. J Neurochem 40:396-401.
27. Juorio AV, Greenshaw AJ, Wishart TB. 1988. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors. Naunyn Schmiedeberg's Arch Pharmacol 338:644-648.
28. Juorio AV, Paterson IA, Zhu M-Y, Matte G. 1991. Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the striatum. J Neurochem 56:213-220.
29. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, Ganapathy V. 1998. Cloning and characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273:15971-15979.
30. Koepsell H, Lips K, Volk C. 2007. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227-1251.
31. Liang YJ, Zhen J, Chen N, Reith ME. 2009. Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters. J Neurochem 109:981-994.
32. Melchior DL. 2002. A rapid empirical method for measuring membrane bilayer entry equilibration of molecules. J Pharm Sci 91:1075-1091.
33. Miller GM. 2012. Avenues for the development of therapeutics that target trace amine-associated receptor 1 (TAAR1). J Med Chem 55:1809-1814.
34. Nissinen E, Linden EB, Schultz E, Kaakkola S, Mannisto PT, Pohto P. 1988. Inhibition of catechol-O-methyl transferase activity by two novel disubstituted catechols in the rat. Eur J Pharmacol 153:263-269.
35. Oldendorf WH. 1971. Brain uptake of radiolabelled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221:629-639.
36. Orlowski A, Grzybek M, Bunker A, Pasenkiewicz-Gierula M, Vattulainen I, Mannisto PT, Rog T. 2012. Strong preferences of dopamine and l-dopa towards lipid head group: importance of lipid composition and implication for neurotransmitter metabolism. J Neurochem 122:681-690.
37. Parker EM, Cubeddu LX. 1988. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J Pharmacol Exp Ther 245:199-210.
38. Paterson IA. 1988. The potentiation of cortical neurone responses to noradrenaline by beta-phenylethylamine: effects of lesions of the locus coeruleus. Neurosci Lett 87:139-144.
39. Paterson IA. 1993. The potentiation of cortical neurone responses to noradrenaline by 2-phenylethylamine is independent of endogenous noradrenaline. Neurochem Res 18:1329-1336.
40. Paterson IA, Boulton AA. 1988 Beta-phenylethylamine enhances single cortical neurone responses to noradrenaline in the rat. Brain Res Bull 20:173-177.
41. Paterson IA, Juorio AV, Boulton AA. 1990. 2-Phenylethylamine: A modulator of catecholamine transmission in the mammalian central nervous system? J Neurochem 55:1827-1837.
42. Paterson IA, Juorio AV, Berry MD, Zhu M-Y. 1991. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum. J Pharmacol Exp Ther 258:1019-1026.
43. Raiteri M, Del Carmine R, Bertollini A, Levi G. 1977. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 41:133-143.
44. Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, Bettler B, Caron MG, Wettstein JG, Hoener MC. 2011. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci USA 108:8485-8490.
45. Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Velazquez-Sanchez C, Sotnikova TD, Morairty SR, Harmeier A, Groebke Zbinden K, Norcross RD, Bradaia A, Kilduff TS, Biemans B, Pouzet B, Caron MG, Canales JJ, Wallace TL, Wettstein JG, Hoener MC. 2012. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiat DOI 10.1016/j.biopsych.2012.05.014.
46. Schomig E, Lazar A, Grundemann D. 2006. Extraneuronal monoamine transporter and organic cation transporters 1 and 2: A review of transport efficiency. Handb Exp Pharmacol 175:151-180.
47. Szmigielski A. 1975. Effect of disulfiram and sodium diethylthiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart. Pol J Pharmacol Pharm 27:153-159.
48. Tchercansky DM, Acevedo C, Rubio MC. 1994. Studies of tyramine transfer and metabolism using an in vitro intestinal preparation. J Pharm Sci 83:549-552.
49. Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P, Branchek T, Gerald CP. 2007. The trace amine 1 receptor knockout mouse: An animal model with relevance to schizophrenia. Genes Brain Behav 6:628-639.
50. Xie Z, Miller GM. 2007. Trace amine-associated receptor 1 is a modulator of the dopamine transporter. J Pharmacol Exp Ther 321:128-136.
51. Xie Z, Miller GM. 2008. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain. J Pharmacol Exp Ther 325:617-628.
52. Xie Z, Miller GM. 2009. A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain. J Pharmacol Exp Ther 330:316-325.
53. Xie Z, Westmoreland SV, Bahn ME, Chen G-L, Yang H, Vallender EJ, Yao WD, Madras BK, Miller GM. 2007. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther 321:116-127.
54. Xie Z, Vallender EJ, Yu N, Kirstein S, Yang H, Bahn M, Westmoreland SV. Miller GM. 2008a. Cloning, expression and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association. J Neurosci Res 86:3435-3446.
55. Xie Z, Westmoreland SV, Miller GM. 2008b. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in HEK293 cells and brain synaptosomes. J Pharmacol Exp Ther 325:629-640.
56. Zhu H-J, Appe, DI, Grundermann D, Markowitz JS. 2010. Interaction of organic cation transporter 3 (SLC22A3) and amphetamine. J Neurochem 114:142-149.